Michael Messinger
Director/Board Member bei FILAMENT HEALTH CORP.
Vermögen: 1 $ am 31.03.2024
Profil
Michael Messinger is currently the Director at Filament Health Corp.
He previously worked as the Finance Director at Lexicon Pharmaceuticals, Inc. from 2001 to 2012.
Before that, he was an Auditor at Ernst & Young LLP from 1996 to 1999 and a Controller at Coelacanth Corp.
from 1999 to 2001.
From 2012 to 2023, he served as the President, Chief Executive & Operating Officer at ContraFect Corp.
Mr. Messinger obtained his undergraduate degree from the University of Michigan.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CONTRAFECT CORP.
0,00% | 06.09.2023 | 23 ( 0,00% ) | 1 $ | 31.03.2024 |
Aktive Positionen von Michael Messinger
Unternehmen | Position | Beginn |
---|---|---|
FILAMENT HEALTH CORP. | Director/Board Member | 28.03.2024 |
Ehemalige bekannte Positionen von Michael Messinger
Unternehmen | Position | Ende |
---|---|---|
CONTRAFECT CORPORATION | Chief Executive Officer | 04.12.2023 |
LEXICON PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.01.2012 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01.01.1999 |
Ausbildung von Michael Messinger
University of Michigan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CONTRAFECT CORPORATION | Health Technology |
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Filament Health Corp. |